AllianceBernstein
AGN

AllianceBernstein’s Allergan plc AGN Stock Holding History

AllianceBernstein’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-163,100
Closed -$31.2M – 3191
2019
Q4 		$31.2M Buy
163,100
+13,100
+9% +$2.36M 0.02% 672
2019
Q3 		$25.2M Buy
+150,000
New +$24.4M 0.02% 716

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

AllianceBernstein's AGN Position: Q2 2020 in Review

AllianceBernstein sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 633,557 shares — an estimated $112M sold.

AllianceBernstein first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $993M in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • AllianceBernstein reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • AllianceBernstein sold 633,557 Allergan plc shares in Q2 2020, an estimated $112M.
  • AllianceBernstein first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • AllianceBernstein's Allergan plc position peaked at $993M in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on AllianceBernstein's 13F filing for Q2 2020, filed 13 Aug 2020.